Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study

INTRODUCTION: Recombinant human activated protein C (rhAPC) is the first drug for which a reduction of mortality in severe sepsis has been demonstrated. However, the mechanism by which this reduction in mortality is achieved is still not clearly defined. The aim of the present study was to evaluate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: de Pont, Anne-Cornélie JM, Bakhtiari, Kamran, Hutten, Barbara A, de Jonge, Evert, Vroom, Margreeth B, Meijers, Joost CM, Büller, Harry R, Levi, Marcel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2005
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297612/
https://ncbi.nlm.nih.gov/pubmed/16277710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3774
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak